DataLibraryResearch is tracking the market dynamics of the crisis in the Pharma & Healthcare industry amid lock-down changes in the supply chain.

Get detailed analysis of the COVID-19 impact on the Bio hacking Market

Global Bio hacking Market Opportunities and Forecast 2020-2027

DLR2236
01 February, 2021
Pharma & Healthcare
Pages: 120
Global

Summary

Global Bio hacking Market, By Type (Inside and Outside Bio-Hacking), By Products (Smart Drugs, Sensors, Strains, and Others) By Application (Synthetic Biology, Forensic Science, Genetic Engineering, Drug Testing, Diagnosis & Treatment, and Others) opportunities and forecast 2020-2027

Market Overview

Bio-hacking is treatment where implants and drug are used in improving cognitive functions both internally and externally, to sharpen memory, cognition, or creativity. It is related to several nootropic drugs that are used to develop focus and intellligence. The rising use of the RFID technology, incorporation of internet of things (IoT), growing inclusion of consumer electronics and fitness, and others can affect the market development. Though, the lack of the security can trigger adverse results. The implantations can be hacked, that can create problems. Though, other factors such as rising elderly population, and will to counter the chronic diseases are anticipated to push market growth in coming years.

Segment Overview

Currently, the wearable analytic technological products are available widely. The present generation have positive approach towards Bio-hacking and devices. Tracking of heart steps, rate, blood sugar level, and the movement of body, burning calories or other metrics, can be labelled as Bio-hacking through the analytics. The choices in terms of the Bio-hacking to keep the track of one’s biological routine are innovative, wide ranging, and ever growing.

Regional Overview

Bio-hacking has brought out absolute change in field of synthetic biology. Bio-hacking have settled an urge of innovation and development of new products. It combines aspects of synthetic biology and technology. Laboratory experiments are directed by the research individuals and scientist to explore the new avenues in genetic engineering, biotechnology, and molecular biology. Bio-hackers embark on the numerous experimentations on body such as insertion of microchips to regulate the stress level and to monitor a heart rate. Bio-hackers have advanced and are in process of developing numerous products to discover the human body. Some of remarkable products include microchips, smart drugs, magnetic fingertips, RFID implants, brain sensors, yeast strains, bacteria, body sensors, and the smart BP monitor health trackers.

Competitor overview

The global market for the bio-hacking is showing huge potential owing to participation shown by numerous companies. The companies are participating substantially to trigger the growth in the market as the investments are concentrating towards numerous market strategies such as merger, innovation, marketing, acquisition, branding, and others. The companies have been reported and
In September 2019, international bio-hacker company confirmed that they are to make a cheaper variety of gene therapy which would considerably lower price in the market and would also assist in the healthier reaching of medicine to numerous patients. The medicine in the question is Glybera which can be used for hereditary diseases and the per treatment costs $ 1 million. The drug is the first-of-its-kind.

Key Players

Synbiota
Thync Global Inc.
HVMN, Inc.
Apple
THE ODIN
MoodMetric
Fitbit, Inc.

Market Segmentation

By Type

Inside Bio-Hacking
Outside Bio-hacking

By Products

Sensors
Smart Drugs
Strains
Others

By Application

Synthetic Biology
Genetic Engineering
Forensic Science
Diagnosis & Treatment
Drug Testing
Others

By Geography

North America
- US
- Canada
Europe
- UK
- Germany
- France
- Italy
- Spain
- Rest of Europe
Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
LAMEA
- Brazil
- Saudi Arabia
- UAE
- Rest of LAMEA

Table of Contents

1 Report Prologue 15

2 Market Introduction 19

2.1 Introduction 19
2.2 Scope of Study 19
2.3 Research Objective 20
2.4 Assumptions & Limitations 20
- 2.4.1 Assumptions 20
- 2.4.2 Limitations 20
2.5 Market Structure 21

3 Research Methodology 22

3.1.1 Primary Research Methodology 23
3.1.2 Secondary Research Methodology 24
3.1.3 Market Share Analysis 25
3.1.4 Trade Analysis 25

3.2 Forecast Model 26

4 Market Dynamics 27

4.1 Introduction 27
4.2 Drivers 28
- 4.2.1 Rising prevalence of chronic disease (45%) 28
- 4.2.2 Growing awareness about biohacking (25%) 29
- 4.2.3 Increasing demand for innovative medical devices and sensors (30%) 30
4.3 Restraints 31
- 4.3.1 Lack of cyber security practices 31
4.4 Opportunities 32
- 4.4.1 Technological advancement 32
4.5 Mega Trends 32
- 4.5.1 Exploration of future biohacking products on rise 32
4.6 Macroeconomic indicators 33

5 Market Factor Analysis 34

5.1 Value Chain Analysis 34
- 5.1.1 Primary activities 34
- 5.1.2 Secondary activities 35
5.2 Porters Five Forces Model 36
- 5.2.1 Bargaining Power of Suppliers 37
- 5.2.2 Bargaining Power of Buyers 37
- 5.2.3 Threat of New Entrants 37
- 5.2.4 Threat of Substitutes 37
- 5.2.5 Intensity of Rivalry 38

6 Global Biohacking Market, By Type 39

6.1 Introduction 39
6.2 Outside Biohacking 40
6.3 Inside Biohacking 40

7 Global Biohacking Market by Product 41

7.1 Introduction 41
7.2 Smart Drugs 42
7.3 Sensors 44
7.4 Strains 45
7.5 Others 46

8 Global Biohacking Market by Application 47

8.1 Introduction 47
8.2 Synthetic Biology 48
8.3 Genetic Engineering 49
8.4 Forensic science 51
8.5 Diagnosis & Treatment 51
8.6 Drug testing 53
8.7 Others 53

9 Global Biohacking Market, By End User 54

9.1 Introduction 54
9.2 Pharmaceutical & Biotechnology Companies 55
9.3 Forensic Laboratories 55
9.4 Others 56

10 Global Biohacking Market, By Region 57

10.1 Introduction 57
10.2 Americas 58
- 10.2.1 U.S. 63
- 10.2.2 Canada 65
- 10.2.3 South America 68
10.3 Europe 72
- 10.3.1 Germany 76
- 10.3.2 France 79
- 10.3.3 U.K 82
- 10.3.4 Italy 85
- 10.3.5 Spain 88
- 10.3.6 Rest of Western Europe 91
- 10.3.7 Eastern Europe 94
10.4 Asia Pacific 98
- 10.4.1 Japan 103
- 10.4.2 China 105
- 10.4.3 India 108
- 10.4.4 Australia 111
- 10.4.5 Republic of Korea 114
- 10.4.6 Rest of Asia Pacific 117
10.5 Middle East & Africa 121
- 10.5.1 United Arab Emirates 125
- 10.5.2 Saudi Arabia 128
- 10.5.3 Oman 131
- 10.5.4 Kuwait 134
- 10.5.5 Qatar 137
- 10.5.6 Rest of Middle East & Africa 140

11 Company Landscape 144

11.1 Introduction: Key Players 144
11.2 Company Share Analysis 144

12 Company Profile 145

12.1 Fitbit, Inc. 145
- 12.1.1 Company Overview 145
- 12.1.2 Financials 145
- 12.1.3 Products 145
- 12.1.4 Strategy 145
- 12.1.5 Key Developments 145
12.2 Apple 146
- 12.2.1 Company Overview 146
- 12.2.2 Financials 146
- 12.2.3 Products 146
- 12.2.4 Strategy 146
- 12.2.5 Key Developments 146
12.3 Synbiota 147
- 12.3.1 Company Overview 147
- 12.3.2 Financials 147
- 12.3.3 Products 147
- 12.3.4 Strategy 147
- 12.3.5 Key Developments 147
12.4 THE ODIN 148
- 12.4.1 Company Overview 148
- 12.4.2 Financials 148
- 12.4.3 Products 148
- 12.4.4 Strategy 148
- 12.4.5 Key Developments 148
12.5 HVMN, Inc. 149
- 12.5.1 Company Overview 149
- 12.5.2 Financials 149
- 12.5.3 Products 149
- 12.5.4 Strategy 149
- 12.5.5 Key Developments 149
12.6 Thync Global Inc., U.S.A. 150
- 12.6.1 Company Overview 150
- 12.6.2 Financials 150
- 12.6.3 Products 150
- 12.6.4 Strategy 150
- 12.6.5 Key Developments 150
12.7 MoodMetric 151
- 12.7.1 Company Overview 151
- 12.7.2 Financials 151
- 12.7.3 Products 151
- 12.7.4 Strategy 151
- 12.7.5 Key Developments 151

13 Conclusion 152

13.1 Key Findings 152
- 13.1.1 CEO’s Viewpoint 152
- 13.1.2 Unmet Needs 152
- 13.1.3 Key Companies to Watch 152
- 13.1.4 Prediction of Biohacking Industry 152

14 Appendix 154

14.1 Discussion Blue Print 154
14.2 References 156

List of Figures